DrugRisk Update: First NuvaRing Lawsuit Starts This Summer As FDA Complaints Rise

Share Article

The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

nuvaring lawsuit
U.S. District Judge Rodney Sippel, who will preside over the federal cases, recently issued an order scheduling the start of trials for July 8, 2013.

The birth control resource center at DrugRisk.com is alerting women who have used NuvaRing contraceptive devices of new safety warnings added to the site. Also, complaints to the FDA over the devices continue to rise as trials are set to begin this summer for more than 1,000 cases.

“DrugRisk’s mission is to improve patient safety by providing the latest drug warnings, recalls, studies and litigation news. We’ve noticed an increase in both injury claims and complaints to the FDA related to NuvaRing following the recent blood clot warnings,” explains DrugRisk representative Ryan Mayer.

The resource center previously added warnings which link vaginal ring contraceptives such as NuvaRing to higher risks of blood clots than traditional birth control pills. On June 14, 2012, the New England Journal of Medicine published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots.*

DrugRisk has also discovered that the FDA has received nearly 5,500 adverse event reports of complications among women using NuvaRing devices.** Most common were 1,177 reports of pulmonary embolism and 806 reports of deep vein thrombosis, with hospitalization resulting in over 30% of cases.**

The resource center has learned that more than 1,000 patients have filed a NuvaRing lawsuit, with many of these moved to a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri. New information shows claims have risen nearly 5% in recent months.***

U.S. District Judge Rodney Sippel, who will preside over the federal cases, recently issued an order scheduling the start of trials for July 8, 2013.**** Therefore, the time to file a claim is limited.

Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of federal MDL drug injury cases, the DrugRisk Center only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

For more information on the research, side effects and litigation news related to NuvaRing blood closts, or to speak with a lawyer, visit http://www.DrugRisk.com.

****Order # 1423, Novenber 20, 2012, Case: 4:08-md-01964-RWS

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
Email >
Visit website